DGX Quest Diagnostics Incorporated Common Stock
NYSE · Health Care · SEC EDGAR पर देखें ↗ बंद अक्ट 6, 2026 10-K/10-Q जुल 23, 2026
$228.39
· 52 सप्ताह की सीमा का %
· निम्न से ऊपर
· उच्च तक
$171.1852w निम्न
$248.8452w उच्च
मार्केट कैप (MRQ)
$25.12B
P/E (TTM)
24.2
EPS (TTM)
$9.42
राजस्व (TTM)
$11.56B
आपके बैज
52W रेंज
$171–$249
विश्लेषक रेटिंग
HOLD
मूल्य लक्ष्य
$248
P/E
24.2
ROE
14.4%
शुद्ध लाभ मार्जिन
9.2%
आपकी बैज स्ट्रिप खाली है — इस पेज पर कहीं भी एक मीट्रिक पिन करें।
DGX स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
मूल्य
$228.39
मार्केट कैप (MRQ)
$25.12B
P/E (TTM)
24.2
EPS (TTM)
$9.42
राजस्व (TTM)
$11.56B
लाभांश प्रतिफल
1.4%
ROE (TTM)
14.4%
D/E ऋण/इक्विटी (MRQ)
0.8
52W रेंज
$171–$249
DGX स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
सीमा
बार
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
स्टॉक विभाजन
| एक्स-डेट | स्प्लिट | प्रकार |
|---|---|---|
| 21 जून 2005 | 2-for-1 | फॉरवर्ड |
| 1 जून 2001 | 2-for-1 | फॉरवर्ड |
Quest Diagnostics Incorporated Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.
History
1960–1995
Originally founded as Metropolitan Pathology Laboratory, Inc. in 1967 by Paul A. Brown, MD, the clinical laboratory underwent a variety of name changes. In 1969, the company's name changed to MetPath, Inc. with headquarters in Teaneck, New Jersey. By 1982, MetPath was acquired by what was then known as Corning Glass Works and was subsequently renamed Corning Clinical Laboratories.
1996–2000
On December 31, 1996, Quest Diagnostics became an independent company as a spin-off from Corning. Kenneth W. Freeman was appointed as CEO during this transition. Over the next year, Quest acquired a clinical laboratory division of Branford, Connecticut–based Diagnostic Medical Laboratory, Inc. (DML). Two years later in 1999, Quest added SmithKline Beecham Clinical Laboratories to their subsidiaries; which includes a joint venture ownership with CompuNet Clinical Laboratory. The purchase of SmithKline Beecham also included the lab's medical sample transport airline (ICAO: LBQ, call sign: LABQUEST) originally founded in 1988.
In 1997, Quest and Banner Health formed a joint venture creating the Arizona based Sonora Quest laboratory, a business unit of Laboratory Sciences of Arizona. This entity represents the operations of Quest Diagnostics in the Arizona regional market.
2001–2015
From May 2004 to April 2012, Surya Mohapatra served as the company's President and CEO. In 2007 Quest acquired diagnostic testing equipment company AmeriPath. In response to Mohapatra's resignation after eight years with Quest, former Philips Healthcare CEO Stephen Rusckowski was appointed. Under Rusckowski, Quest Diagnostics teamed up with central New England's largest health care system, UMass Memorial Health Care, to purchase its clinical outreach laboratory.
2016–present
In 2016, Quest collaborated with Safeway to bring testing services to twelve of its stores in California, Maryland, Virginia, Texas and Colorado.
By the end of 2017, Quest, in partnership with Walmart, incorporated laboratory testing in about 15 of their locations in Texas and Florida.
In May 2018, the company announced it will become an in-network laboratory provider to UnitedHealthcare starting in 2019, providing access to 48 million plan members.
In September 2018, Quest moved its headquarters from Madison, where it was located since 2007, to Secaucus, New Jersey.
In November 2018, Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing from home.
In March 2020, the company launched a COVID-19 testing service. As of July 2020, Quest had performed more than 9.2 million COVID-19 molecular tests and 2.8 million serology tests.
In April 2024, Quest has added a new blood screening to their AD-Detect product line. This test will analyze the blood for a specific Alzheimer's protein, pTau-217.
In February 2025, Quest acquired select assets of Fresenius Medical Care's Spectra laboratories. Under a separate agreement, Quest now offers clinical testing and lab services related to dialysis and end-stage kidney disease.
Acquisitions
Partnerships
2005: Forms a strategic alliance with Ciphergen Biosystems to commercialize novel proteomic tests.
Controversies
Quest Diagnostics set a record in April 2009 when it paid $302 million to the government to settle a Medicare fraud case alleging the company sold faulty medical testing kits. It was the largest qui tam (whistleblower) settlement paid by a medical laboratory for manufacturing and distributing a faulty product. In May 2011, Quest paid $241 million to the state of California to settle a False Claims Act case that alleged the company had overcharged Medi-Cal, the state's Medicaid program, and provided illegal kickbacks as incentives for healthcare providers to use Quest labs.
In 2018, Quest Diagnostics was among a number of U.S.–based laboratories linked to inaccuracies of over 200 women's cervical smear tests for CervicalCheck, Ireland's national screening program. Audits of the testing performed by Quest (and another subcontractor, Clinical Pathology Laboratories, Inc. of Austin, Texas) showed a high rate of errors in analysis of samples which led to lawsuits and a government inquiry. Quest and the Irish government continue to settle the resulting lawsuits.
On June 3, 2019, Quest announced that American Medical Collection Agency (AMCA), a billing collections service provider, had informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest. AMCA provides billing collections services to Optum360, which in turn is a Quest contractor. AMCA later went bankrupt after the breach.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
क्षेत्रHealth Care
उद्योगHealth Care
कर्मचारी46000
देशUS
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
राजस्व$11.04B2016-12-31 → 2025-12-31
EPS$8.752016-12-31 → 2025-12-31
फ्री कैश फ्लो$1.36B2016-12-31 → 2025-12-31
शुद्ध मार्जिन9.2%2016-12-31 → 2025-12-31
मूल्यांकन और अनुपात
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | DGX | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 24.25Y औसत ≈17.7 | ≈17.7 | 23.3 | अल्पमूल्यित | |
| P/S (TTM) | 2.25Y औसत ≈1.7 | ≈1.7 | 1.3 | अति मूल्यांकित | |
| P/B (MRQ) | 3.35Y औसत ≈2.7 | ≈2.7 | 2.9 | उचित मूल्य | |
| EV / EBITDA | 14.45Y औसत ≈11.0 | ≈11.0 | 11.4 | उचित मूल्य | |
| मूल्य / FCF (TTM) | 18.65Y औसत ≈14.9 | ≈14.9 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 13.25Y औसत ≈10.8 | ≈10.8 | 9.8 | उचित मूल्य | |
| EV / Revenue (EV / राजस्व) | 2.85Y औसत ≈2.2 | ≈2.2 | · | · | |
| EV / FCF | 22.55Y औसत ≈18.8 | ≈18.8 | · | · | |
| मूल्य / मूर्त पुस्तक (MRQ) | 4.3 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | DGX | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| परिचालन मार्जिन (TTM) | 14.1%5Y औसत ≈15.6% | ≈15.6% | 8.3% | शीर्ष स्तर | |
| EBITDA मार्जिन (TTM) | 19.1%5Y औसत ≈20.2% | ≈20.2% | 8.8% | शीर्ष स्तर | |
| प्रीटैक्स मार्जिन (TTM) | 12.1%5Y औसत ≈14.5% | ≈14.5% | 3.8% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | 9.2%5Y औसत ≈11.0% | ≈11.0% | 5.1% | शीर्ष स्तर | |
| ROA (TTM) | 6.5%5Y औसत ≈8.0% | ≈8.0% | 4.0% | शीर्ष स्तर | |
| ROE (TTM) | 14.4%5Y औसत ≈17.4% | ≈17.4% | 12.5% | अनुरूप | |
| ROIC | 9.2%5Y औसत ≈11.0% | ≈11.0% | 9.2% | अनुरूप |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | DGX | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | 0.85Y औसत ≈0.8 | ≈0.8 | 0.4 | उच्च ऋण | |
| वर्तमान अनुपात (MRQ) | 1.65Y औसत ≈1.2 | ≈1.2 | 1.4 | मजबूत तरलता | |
| Quick Ratio (त्वरित अनुपात) | 0.85Y औसत ≈1.0 | ≈1.0 | 0.8 | मजबूत तरलता | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | 0.75Y औसत ≈0.7 | ≈0.7 | 0.7 | उच्च ऋण |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | DGX | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 11.8%5Y औसत ≈3.6% | ≈3.6% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 3.7%5Y औसत ≈0.06% | ≈0.06% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 3.2% | · | · | · | |
| EPS YoY | 13.8%5Y औसत ≈2.0% | ≈2.0% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 13.9%5Y औसत ≈-1.4% | ≈-1.4% | · | · | |
| EPS CAGR 3Y | 3.2%5Y औसत ≈-9.4% | ≈-9.4% | · | · | |
| EPS CAGR 5Y | -3.5% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | 1.6%5Y औसत ≈-12.8% | ≈-12.8% | · | · | |
| Net Income CAGR 5Y (शुद्ध आय CAGR 5Y) | -7.1% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | DGX | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 0.75Y औसत ≈0.7 | ≈0.7 | 1.2 | कमजोर | |
| Inventory Turnover (इन्वेंटरी टर्नओवर) | 39.15Y औसत ≈33.9 | ≈33.9 | 15.6 | शीर्ष स्तर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 8.15Y औसत ≈7.7 | ≈7.7 | 10.5 | कमजोर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$239.9K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
लाभांश यील्ड1.4%
भुगतान अनुपात35.6%
वार्षिक भुगतान≈$3.44
5Y लाभांश CAGR≈7.4%
विकास की लकीर≈14
| एक्स-डेट | राशि | मुद्रा | यील्ड |
|---|---|---|---|
| जुल 8, 2026 | $0.86 | USD | ≈1.6% |
| अप्र 6, 2026 | $0.86 | USD | ≈1.6% |
| जन 13, 2026 | $0.80 | USD | ≈1.8% |
| अक्ट 3, 2025 | $0.80 | USD | ≈1.8% |
| जुल 7, 2025 | $0.80 | USD | ≈1.8% |
| अप्र 7, 2025 | $0.80 | USD | ≈1.9% |
| जन 14, 2025 | $0.75 | USD | ≈2.0% |
| अक्ट 4, 2024 | $0.75 | USD | ≈2.0% |
| जुल 8, 2024 | $0.75 | USD | ≈2.1% |
| अप्र 5, 2024 | $0.75 | USD | ≈2.2% |
| जन 16, 2024 | $0.71 | USD | ≈2.1% |
| अक्ट 5, 2023 | $0.71 | USD | ≈2.3% |
| जुल 10, 2023 | $0.71 | USD | ≈2.0% |
| अप्र 6, 2023 | $0.71 | USD | ≈1.9% |
| जन 17, 2023 | $0.66 | USD | ≈1.8% |
| अक्ट 3, 2022 | $0.66 | USD | ≈2.1% |
| जुल 5, 2022 | $0.66 | USD | ≈1.9% |
| अप्र 5, 2022 | $0.66 | USD | ≈1.9% |
| जन 18, 2022 | $0.62 | USD | ≈1.8% |
| अक्ट 4, 2021 | $0.62 | USD | ≈1.7% |
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
औसत आश्चर्य
3.6%
अगली रिपोर्ट
अक्ट 19, 2026
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | जुल 20, 2026 | $3.12 | $2.85 | 9.3% |
| 31 मार्च 2026 | $2.50 | $2.37 | 5.5% | |
| 31 दिसमबर 2025 | $2.42 | $2.38 | 1.5% | |
| 30 सितमबर 2025 | $2.60 | $2.53 | 2.8% | |
| 30 जून 2025 | $2.62 | $2.60 | 0.93% | |
| 31 मार्च 2025 | $2.21 | $2.17 | 1.7% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Cost of Revenue | $7.37B | $6.63B | $6.20B | $6.45B | $6.58B | $5.80B | $5.04B | $4.93B | $4.72B | $4.62B | $4.66B | $4.64B | |
| Gross Profit | · | · | · | · | · | $3.63B | $2.69B | $2.60B | $2.68B | $2.90B | $2.84B | $2.80B | |
| SG&A Expense | $1.97B | $1.77B | $1.64B | $1.87B | $1.73B | $1.55B | $1.46B | $1.42B | $1.44B | $1.38B | $1.68B | $1.73B | |
| Operating Expenses | $9.48B | $8.53B | $7.99B | $8.46B | $8.41B | $7.47B | $6.50B | $6.43B | $6.24B | $5.94B | $6.09B | $6.45B | |
| Operating Income | $1.56B | $1.35B | $1.26B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.28B | $1.40B | $983M | |
| Interest Expense | · | · | $163M | $148M | $152M | $166M | $180M | $169M | $153M | $144M | $154M | $167M | |
| Interest Income | $13M | $25M | $11M | $10M | $1M | $3M | $5M | $2M | $2M | $1M | $1M | $3M | |
| Other Non-op | $26M | $30M | $20M | $-55M | $369M | $76M | $20M | $-8M | $16M | $-48M | $-143M | $4M | |
| Pretax Income | $1.32B | $1.18B | $1.13B | $1.24B | $2.60B | $1.88B | $1.08B | $926M | $1.03B | $1.09B | $1.10B | $823M | |
| Income Tax | $314M | $273M | $248M | $264M | $597M | $460M | $247M | $182M | $241M | $429M | $373M | $262M | |
| Net Income | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| EPS (Basic) | $8.87 | $7.78 | $7.59 | $8.10 | $15.85 | $10.62 | $6.36 | $5.39 | $5.63 | $4.58 | $4.92 | $3.83 | |
| EPS (Diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 | |
| Shares (Basic) | 111,000,000 | 111,000,000 | 112,000,000 | 116,000,000 | 125,000,000 | 134,000,000 | 134,000,000 | 136,000,000 | 137,000,000 | 140,000,000 | 144,000,000 | 145,000,000 | |
| Shares (Diluted) | 113,000,000 | 113,000,000 | 113,000,000 | 118,000,000 | 128,000,000 | 136,000,000 | 136,000,000 | 139,000,000 | 140,000,000 | 142,000,000 | 145,000,000 | 145,000,000 | |
| EBITDA | $2.13B | $1.84B | $1.70B | $1.86B | $2.79B | $2.33B | $1.56B | $1.41B | $1.44B | $1.53B | $1.70B | $1.30B |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420M | $549M | $686M | $315M | $872M | $1.16B | $1.19B | $135M | $137M | $359M | $133M | $192M | |
| Receivables | $1.41B | $1.30B | $1.21B | $1.20B | $1.44B | $1.52B | $1.06B | $1.01B | $924M | $926M | $901M | $932M | |
| Inventory | $189M | $188M | $190M | $192M | $208M | $223M | $123M | $99M | $95M | $82M | $84M | $110M | |
| Prepaid Expense | $361M | $351M | $286M | $196M | $223M | $157M | $112M | $144M | $150M | $155M | $207M | $186M | |
| Current Assets | $2.38B | $2.39B | $2.37B | $1.90B | $2.74B | $3.06B | $2.49B | $1.39B | $1.31B | $1.53B | $1.50B | $1.60B | |
| PP&E (Net) | $2.20B | $2.11B | $1.82B | $1.77B | $1.71B | $1.63B | $1.45B | $1.29B | $1.15B | $1.03B | $925M | $933M | |
| PP&E (Gross) | $6.18B | $5.77B | $5.23B | $5.10B | $4.79B | $4.62B | $4.23B | $3.97B | $3.67B | $3.43B | $3.23B | $3.13B | |
| Accum. Depreciation | $3.97B | $3.66B | $3.42B | $3.34B | $3.09B | $2.99B | $2.78B | $2.68B | $2.53B | $2.40B | $2.31B | $2.19B | |
| Goodwill | $8.95B | $8.86B | $7.73B | $7.22B | $7.09B | $6.87B | $6.62B | $6.56B | $6.33B | $6.00B | $5.91B | $6.03B | |
| Intangibles | $1.64B | $1.76B | $1.17B | $1.09B | $1.17B | $1.17B | $1.12B | $1.21B | $1.12B | $949M | $984M | $1.07B | |
| Other Non-current Assets | $270M | $255M | $198M | $144M | $163M | $176M | $160M | $119M | $136M | $148M | $174M | $172M | |
| Total Assets | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Accounts Payable | $1.60B | $1.39B | $1.36B | $1.40B | $1.60B | $1.63B | $1.04B | $1.02B | $1.02B | $975M | $1.01B | $1.19B | |
| Accrued Liabilities | $338M | $306M | $287M | $392M | $460M | $356M | $223M | $274M | $246M | $254M | $257M | $277M | |
| Current Liabilities | $2.28B | $2.17B | $1.81B | $1.55B | $1.75B | $1.78B | $1.99B | $1.49B | $1.06B | $981M | $1.17B | $1.71B | |
| Capital Leases | $537M | $535M | $503M | $489M | $494M | $499M | $413M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $264M | $243M | $170M | $191M | $157M | $204M | |
| Other Non-current Liabilities | $957M | $938M | $876M | $812M | $792M | $847M | $711M | $745M | $663M | $654M | $514M | $594M | |
| Long-term Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.74B | |
| Total Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.76B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $9.99B | $9.36B | $8.82B | $8.29B | $7.65B | $9.30B | $8.17B | $7.60B | $7.14B | $6.61B | $6.20B | $5.72B | |
| Treasury Stock | $5.18B | $4.86B | $4.83B | $4.67B | $3.45B | $5.37B | $5.22B | $5.00B | $4.78B | $4.46B | $3.96B | $3.81B | |
| AOCI | $-27M | $-88M | $-14M | $-21M | $-14M | $-21M | $-39M | $-59M | $-48M | $-72M | $-38M | $-27M | |
| Stockholders' Equity | $7.17B | $6.78B | $6.31B | $5.89B | $6.44B | $6.76B | $5.64B | $5.22B | $4.92B | $4.63B | $4.68B | $4.30B | |
| Liabilities + Equity | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 119,000,000 | 133,000,000 | 133,000,000 | 135,000,000 | 135,000,000 | 137,000,000 | 143,000,000 | 144,000,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $570M | $493M | $439M | $437M | $408M | $361M | $329M | $309M | $270M | $249M | $304M | $314M | |
| Stock-based Comp | $88M | $88M | $77M | $77M | $79M | $97M | $56M | $61M | $79M | $69M | $52M | $51M | |
| Deferred Tax | $105M | $13M | $-49M | $1M | $-57M | $85M | $15M | $73M | $9M | $37M | $112M | $23M | |
| Amort. of Intangibles | $154M | $127M | $108M | $120M | $103M | $103M | $96M | $90M | $74M | $72M | $81M | $94M | |
| Restructuring | · | · | · | $55M | $13M | $14M | $-3M | $49M | $30M | $11M | $39M | $43M | |
| Other Non-cash | $131M | $-131M | $-49M | $257M | $-192M | $31M | $-15M | $21M | $45M | $69M | $-367M | $-6M | |
| Operating Cash Flow | $1.89B | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.12B | $821M | $944M | |
| CapEx | $527M | $425M | $408M | $404M | $403M | $418M | $400M | $383M | $252M | $293M | $263M | $308M | |
| Investing Cash Flow | $-631M | $-2.55B | $-1.06B | $-543M | $21M | $-772M | $-411M | $-801M | $-830M | $-127M | $-362M | $-1.02B | |
| Stock Repurchased | $450M | $151M | $275M | $1.41B | $2.20B | $325M | $353M | $322M | $465M | $590M | $224M | $132M | |
| Net Stock Activity | $-450M | $-151M | $-275M | $-1.41B | $-2.20B | $-325M | $-353M | $-322M | $-465M | $-590M | $-224M | $-132M | |
| Dividends Paid | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M | |
| Financing Cash Flow | $-1.39B | $1.08B | $160M | $-1.73B | $-2.54B | $-1.27B | $225M | $-401M | $-592M | $-738M | $-518M | $86M | |
| Net Change in Cash | $-129M | $-137M | $371M | $-557M | $-286M | · | · | · | $-222M | $226M | $-59M | $5M | |
| Taxes Paid | $169M | $256M | $317M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.36B | $909M | $864M | $1.31B | $1.83B | $1.59B | $843M | $817M | $923M | $776M | $547M | $630M | |
| Levered FCF | · | · | $737M | $1.20B | $1.71B | $1.46B | $704M | $681M | $806M | $689M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 38.5% | 34.8% | 34.6% | 38.8% | 38.6% | 37.9% | 37.6% | |
| Operating Margin | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.1% | 17.0% | 18.7% | 13.2% | |
| Net Margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.0% | 8.6% | 9.5% | 7.5% | |
| Pretax Margin | 11.9% | 11.9% | 12.2% | 12.5% | 24.1% | 20.0% | 13.9% | 12.3% | 13.4% | 14.4% | 14.7% | · | |
| EBITDA Margin | 19.3% | 18.6% | 18.4% | 18.9% | 25.9% | 24.7% | 20.2% | 18.7% | 18.6% | 20.3% | 22.7% | 17.4% | |
| ROA | 6.1% | 5.8% | 6.4% | 7.1% | 14.4% | 10.7% | 7.2% | 6.8% | 7.5% | 6.4% | 7.1% | 5.9% | |
| ROE | 14.2% | 13.3% | 14.0% | 15.3% | 30.2% | 23.1% | 15.8% | 14.5% | 16.2% | 13.9% | 15.8% | 13.5% | |
| ROIC | 9.2% | 8.0% | 8.9% | 11.4% | 17.5% | 13.8% | 9.1% | 9.7% | 10.2% | 9.2% | 11.1% | · |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 | 1.7 | 1.3 | 0.9 | 1.2 | 1.6 | 1.3 | 0.9 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 | 1.5 | 1.1 | 0.8 | 1.0 | 1.3 | 0.9 | 0.7 | |
| Debt / Equity | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 | |
| Interest Coverage | · | · | 7.7 | 9.6 | 15.7 | 11.9 | 6.8 | 6.5 | 7.6 | 8.9 | · | · |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
| Inventory Turnover | 39.1 | 35.1 | 32.5 | 32.2 | 30.5 | 33.5 | 45.4 | 50.8 | 53.3 | 55.6 | 48.0 | 46.1 | |
| Receivables Turnover | 8.1 | 7.9 | 7.7 | 7.5 | 7.3 | 7.3 | 7.4 | 7.8 | 8.3 | 8.2 | 8.2 | 8.3 |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $65.18 | $61.06 | $56.82 | $53.09 | $54.15 | $50.82 | $42.41 | $38.64 | $36.45 | $33.78 | $32.76 | $29.87 | |
| Revenue / Share | $97.65 | $87.36 | $81.88 | $83.75 | $84.28 | $69.39 | $56.81 | $54.18 | $55.06 | $52.92 | $51.68 | $51.28 | |
| Cash Flow / Share | $16.69 | $11.81 | $11.26 | $14.56 | $17.45 | $14.74 | $9.14 | $8.63 | $8.39 | $7.53 | $5.59 | $6.47 | |
| Cash / Share | $3.82 | $4.95 | $6.18 | $2.84 | $7.33 | $8.71 | $8.96 | $1.00 | $1.01 | $2.62 | $0.93 | $1.33 | |
| Dividend / Share | · | · | · | · | · | · | · | · | $1.80 | $1.65 | $1.52 | $1.32 | |
| EPS (TTM) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 6.7% | -6.4% | -8.4% | 14.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 3.7% | -2.9% | -0.66% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 13.8% | 2.7% | -6.0% | -48.8% | 48.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.2% | -20.9% | -10.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 13.9% | 2.0% | -9.7% | -52.6% | 39.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.6% | -24.1% | -15.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 3.5% | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Net Income TTM | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| Market Cap | $19.09B | $16.75B | $15.30B | $17.36B | $20.59B | $15.85B | $14.20B | $11.24B | $13.30B | $12.59B | $10.17B | $9.66B | |
| Enterprise Value | $24.34B | $22.41B | $19.33B | $21.03B | $23.73B | $18.71B | $17.78B | $15.00B | $16.94B | $15.97B | $13.69B | $13.23B | |
| P/E | 19.8 | 19.6 | 18.4 | 19.6 | 11.1 | 11.4 | 17.0 | 15.7 | 17.9 | 20.4 | 14.6 | 17.6 | |
| P/S | 1.7 | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.8 | 1.5 | 1.8 | 1.7 | 1.4 | 1.3 | |
| P/B | 2.7 | 2.5 | 2.4 | 2.9 | 3.2 | 2.3 | 2.5 | 2.2 | 2.7 | 2.7 | 2.2 | 2.2 | |
| P / Cash Flow | 10.1 | 12.6 | 12.0 | 10.1 | 9.2 | 7.9 | 11.4 | 9.4 | 11.3 | 11.8 | 12.6 | 10.3 | |
| P / FCF | 14.0 | 18.4 | 17.7 | 13.2 | 11.3 | 10.0 | 16.8 | 13.8 | 14.4 | 16.2 | 18.6 | 15.3 | |
| EV / EBITDA | 11.4 | 12.2 | 11.4 | 11.3 | 8.5 | 8.0 | 11.4 | 10.6 | 11.8 | 10.5 | 8.0 | 10.2 | |
| EV / FCF | 17.9 | 24.7 | 22.4 | 16.0 | 13.0 | 11.8 | 21.1 | 18.4 | 18.4 | 20.6 | 25.0 | 21.0 | |
| EV / Revenue | 2.2 | 2.3 | 2.1 | 2.1 | 2.2 | 2.0 | 2.3 | 2.0 | 2.3 | 2.2 | 1.8 | 1.8 | |
| Dividend Yield | 1.8% | 2.0% | 2.1% | 1.8% | 1.5% | 1.9% | 2.0% | 2.4% | 1.9% | 1.8% | 2.1% | 1.9% | |
| Earnings Yield | 5.0% | 5.1% | 5.4% | 5.1% | 9.0% | 8.8% | 5.9% | 6.3% | 5.6% | 4.9% | 6.9% | 5.7% | |
| Payout Ratio | 35.6% | 38.0% | 36.8% | 32.2% | 15.5% | 20.8% | 33.3% | 36.1% | 32.0% | 34.6% | 29.9% | 33.6% | |
| Annual Payout | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B | $2.40B | $2.37B | $2.29B | $2.29B | $2.34B | $2.33B | $2.33B | $2.49B | |
| Cost of Revenue | $2.02B | $1.95B | $1.90B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B | $1.59B | $1.59B | $1.55B | $1.54B | $1.55B | $1.56B | $1.57B | $1.62B | |
| SG&A Expense | $529M | $504M | $504M | $501M | $486M | $476M | $466M | $448M | $416M | $440M | $407M | $380M | $416M | $439M | $563M | $464M | |
| Operating Expenses | $2.58B | $2.50B | $2.42B | $2.43B | $2.32B | $2.31B | $2.26B | $2.16B | $2.04B | $2.07B | $2.02B | $1.95B | $1.99B | $2.03B | $2.20B | $2.09B | |
| Operating Income | $459M | $399M | $386M | $386M | $438M | $346M | $361M | $330M | $355M | $300M | $267M | $342M | $348M | $305M | $135M | $392M | |
| Interest Expense | · | · | · | · | · | · | · | · | $47M | $49M | · | $41M | $39M | $37M | · | $37M | |
| Interest Income | $5M | $2M | $3M | $3M | $2M | $5M | $7M | $9M | $3M | $6M | $6M | $1M | $2M | $2M | $4M | $4M | |
| Other Non-op | $16M | $-2M | $8M | $8M | $13M | $-3M | $3M | $15M | $3M | $9M | $10M | $-3M | $6M | $7M | $6M | $-8M | |
| Pretax Income | $412M | $334M | $330M | $328M | $384M | $276M | $299M | $296M | $314M | $266M | $237M | $299M | $317M | $277M | $109M | $351M | |
| Income Tax | $88M | $74M | $81M | $77M | $97M | $59M | $68M | $65M | $74M | $66M | $40M | $68M | $75M | $65M | $-4M | $81M | |
| Net Income | $320M | $252M | $245M | $245M | $282M | $220M | $222M | $226M | $229M | $194M | $192M | $225M | $235M | $202M | $101M | $256M | |
| EPS (Basic) | $2.88 | $2.27 | $2.21 | $2.18 | $2.51 | $1.97 | $1.98 | $2.01 | $2.05 | $1.74 | $1.72 | $1.99 | $2.08 | $1.80 | $0.93 | $2.20 | |
| EPS (Diluted) | $2.84 | $2.24 | $2.18 | $2.16 | $2.47 | $1.94 | $1.95 | $1.99 | $2.03 | $1.72 | $1.70 | $1.96 | $2.05 | $1.78 | $0.92 | $2.17 | |
| Shares (Basic) | 111,000,000 | 110,000,000 | · | 112,000,000 | 112,000,000 | 111,000,000 | · | 112,000,000 | 111,000,000 | 111,000,000 | · | 112,000,000 | 112,000,000 | 112,000,000 | · | 116,000,000 | |
| Shares (Diluted) | 112,000,000 | 112,000,000 | · | 113,000,000 | 113,000,000 | 113,000,000 | · | 113,000,000 | 112,000,000 | 112,000,000 | · | 114,000,000 | 114,000,000 | 113,000,000 | · | 118,000,000 | |
| EBITDA | $605M | $546M | · | $528M | $581M | $486M | · | $455M | $472M | $416M | · | $453M | $460M | $412M | · | $500M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $626M | $393M | $420M | $432M | $319M | $188M | $549M | $764M | $271M | $474M | · | $143M | $126M | $175M | · | $700M | |
| Receivables | $1.67B | $1.59B | $1.41B | $1.46B | $1.42B | $1.40B | $1.30B | $1.38B | $1.32B | $1.32B | · | $1.28B | $1.24B | $1.25B | · | $1.28B | |
| Inventory | $233M | $225M | $189M | $186M | $187M | $189M | $188M | $184M | $182M | $181M | · | $184M | $184M | $190M | · | $183M | |
| Prepaid Expense | $319M | $361M | $361M | $333M | $273M | $294M | $351M | $299M | $245M | $251M | · | $207M | $188M | $195M | · | $171M | |
| Current Assets | $2.84B | $2.57B | $2.38B | $2.41B | $2.20B | $2.08B | $2.39B | $2.62B | $2.02B | $2.23B | · | $1.81B | $1.73B | $1.81B | · | $2.33B | |
| PP&E (Net) | $2.22B | $2.19B | $2.20B | $2.15B | $2.12B | $2.10B | $2.11B | $2.09B | $1.83B | $1.81B | · | $1.83B | $1.81B | $1.79B | · | $1.71B | |
| PP&E (Gross) | · | · | $6.18B | · | · | · | $5.77B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.97B | · | · | · | $3.66B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $9.11B | $9.12B | $8.95B | $8.90B | $8.88B | $8.85B | $8.86B | $8.61B | $7.88B | $7.83B | $7.73B | $7.73B | $7.73B | $7.24B | $7.22B | $7.19B | |
| Intangibles | $1.67B | $1.72B | $1.64B | $1.66B | $1.71B | $1.73B | $1.76B | $1.72B | $1.20B | $1.19B | · | $1.22B | $1.25B | $1.08B | · | $1.11B | |
| Other Non-current Assets | $277M | $256M | $270M | $296M | $271M | $260M | $255M | $272M | $216M | $182M | · | $149M | $152M | $150M | · | $132M | |
| Total Assets | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Accounts Payable | $1.60B | $1.50B | $1.60B | $1.46B | $1.35B | $1.27B | $1.39B | $1.31B | $1.25B | $1.24B | · | $1.16B | $1.20B | $1.20B | · | $1.45B | |
| Accrued Liabilities | · | · | $338M | · | · | · | $306M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $1.79B | $2.18B | $2.28B | $2.13B | $2.02B | $1.44B | $2.17B | $2.09B | $2.01B | $2.30B | · | $1.62B | $1.88B | $1.35B | · | $1.60B | |
| Capital Leases | $561M | $574M | $537M | $534M | $540M | $538M | $535M | $543M | $507M | $489M | · | $505M | $508M | $490M | · | $505M | |
| Other Non-current Liabilities | $1.06B | $1.02B | $957M | $982M | $890M | $917M | $938M | $891M | $811M | $817M | · | $874M | $901M | $809M | · | $787M | |
| Long-term Debt | $5.64B | · | $5.67B | · | · | · | $6.22B | $6.25B | · | · | · | · | · | · | · | · | |
| Total Debt | $5.64B | $503M | · | $504M | $504M | $1M | · | $6.25B | $606M | $906M | · | $304M | $518M | $2M | · | $2M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Retained Earnings | $10.37B | $10.15B | $9.99B | $9.84B | $9.68B | $9.49B | $9.36B | $9.22B | $9.08B | $8.94B | · | $8.71B | $8.57B | $8.41B | · | $8.26B | |
| Treasury Stock | $5.17B | $5.09B | $5.18B | $4.90B | $4.77B | $4.79B | $4.86B | $4.73B | $4.76B | $4.78B | · | $4.57B | $4.59B | $4.61B | · | $4.27B | |
| AOCI | $-62M | $-43M | $-27M | $-40M | $-16M | $-83M | $-88M | $-15M | $-19M | $-16M | · | $-20M | $-16M | $-18M | · | $-31M | |
| Stockholders' Equity | $7.52B | $7.37B | $7.17B | $7.26B | $7.23B | $6.93B | $6.78B | $6.81B | $6.62B | $6.43B | · | $6.42B | $6.25B | $6.05B | · | $6.24B | |
| Liabilities + Equity | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | $13.22B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 110,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 114,000,000 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $146M | $147M | $145M | $142M | $143M | $140M | $135M | $125M | $117M | $116M | $109M | $111M | $112M | $107M | $116M | $108M | |
| Stock-based Comp | $23M | $20M | $25M | $20M | $21M | $22M | $27M | $19M | $20M | $22M | $19M | $18M | $16M | $24M | $22M | $18M | |
| Deferred Tax | $-2M | $48M | $-13M | $110M | $1M | $7M | $34M | $15M | $-18M | $-18M | $-10M | $-23M | $-12M | $-4M | $-44M | $65M | |
| Amort. of Intangibles | $38M | $37M | $37M | $39M | $39M | $39M | $37M | $32M | $29M | $29M | $27M | $27M | $28M | $26M | $39M | $27M | |
| Restructuring | · | · | · | $6M | $1M | · | · | $7M | $8M | · | · | $1M | $1M | · | · | · | |
| Other Non-cash | · | $-189M | · | · | · | $-75M | · | · | · | $-160M | · | · | · | $-235M | · | · | |
| Operating Cash Flow | $597M | $278M | $465M | $563M | $544M | $314M | $464M | $356M | $360M | $154M | $527M | $207M | $444M | $94M | $334M | $502M | |
| CapEx | $138M | $114M | $158M | $144M | $108M | $117M | $123M | $106M | $92M | $104M | $72M | $105M | $104M | $127M | $147M | $118M | |
| Investing Cash Flow | $-134M | $-152M | $-191M | $-201M | $-124M | $-115M | $-502M | $-1.63B | $-200M | $-213M | $-114M | $-107M | $-682M | $-158M | $-174M | $-118M | |
| Stock Repurchased | · | · | $300M | $150M | · | · | $151M | · | · | · | $275M | $0 | $0 | $0 | $461M | $374M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $96M | $88M | $90M | $89M | $90M | $84M | $84M | $84M | $84M | $79M | $80M | $80M | $80M | $74M | $75M | $78M | |
| Financing Cash Flow | $-229M | $-152M | $-287M | $-247M | $-293M | $-561M | $-170M | $1.77B | $-363M | $-153M | $130M | $-83M | $189M | $-76M | $-545M | $-474M | |
| Net Change in Cash | $233M | $-27M | $-12M | $113M | $131M | $-361M | $-215M | $493M | $-203M | $-212M | $543M | $17M | $-49M | $-140M | $-385M | $-90M | |
| Free Cash Flow | · | $164M | · | · | · | $197M | · | · | · | $50M | · | · | · | $-33M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $13M | · | · | · | $-61M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.1% | 13.8% | · | 13.7% | 15.9% | 13.1% | · | 13.3% | 14.8% | 12.7% | · | 14.9% | 14.9% | 13.1% | · | 15.8% | |
| Net Margin | 10.5% | 8.7% | · | 8.7% | 10.2% | 8.3% | · | 9.1% | 9.6% | 8.2% | · | 9.8% | 10.1% | 8.7% | · | 10.3% | |
| Pretax Margin | 13.5% | 11.5% | · | 11.7% | 13.9% | 10.4% | · | 11.9% | 13.1% | 11.2% | · | 13.0% | 13.6% | 11.9% | · | 14.1% | |
| EBITDA Margin | 19.9% | 18.9% | · | 18.8% | 21.0% | 18.3% | · | 18.3% | 19.7% | 17.6% | · | 19.7% | 19.7% | 17.7% | · | 20.1% | |
| ROA | 1.9% | 1.6% | · | 1.5% | 1.9% | 1.5% | · | 1.5% | 1.7% | 1.5% | · | 1.7% | 1.8% | 1.5% | · | 1.9% | |
| ROE | 4.3% | 3.5% | · | 3.5% | 4.1% | 3.3% | · | 3.4% | 3.6% | 3.1% | · | 3.5% | 3.7% | 3.2% | · | 4.0% | |
| ROIC | 2.7% | 4.0% | · | 3.8% | 4.2% | 3.9% | · | 2.0% | 3.8% | 3.1% | · | 3.9% | 3.9% | 3.9% | · | 4.8% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.2 | · | 1.1 | 1.1 | 1.4 | · | 1.3 | 1.0 | 1.0 | · | 1.1 | 0.9 | 1.3 | · | 1.5 | |
| Quick Ratio | 1.3 | 0.9 | · | 0.9 | 0.9 | 1.1 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | 0.7 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.8 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.9 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.7 | · | · | · | · | · | · | 0.8 | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | 7.6 | 6.1 | · | 8.3 | 8.9 | 8.2 | · | 10.6 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 9.6 | 9.4 | · | 10.1 | 9.9 | 9.7 | · | 9.1 | 8.7 | 8.6 | · | 8.4 | 8.3 | 8.1 | · | 8.3 | |
| Receivables Turnover | 2.0 | 1.9 | · | 2.0 | 2.0 | 1.9 | · | 1.9 | 1.9 | 1.8 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $68.33 | $66.36 | · | $65.39 | $64.54 | $61.87 | · | $60.79 | $59.61 | $57.95 | · | $57.37 | $55.79 | $54.02 | · | $54.69 | |
| Revenue / Share | $27.17 | $25.85 | · | $24.92 | $24.43 | $23.47 | · | $22.02 | $21.40 | $21.12 | · | $20.13 | $20.51 | $20.63 | · | $21.07 | |
| Cash Flow / Share | · | $2.48 | · | · | · | $2.78 | · | · | · | $1.38 | · | · | · | $0.83 | · | · | |
| Cash / Share | $5.69 | $3.54 | · | $3.89 | $2.85 | $1.68 | · | $6.82 | $2.44 | $4.27 | · | $1.28 | $1.12 | $1.56 | · | $6.14 | |
| Dividend / Share | $0.86 | $0.86 | $0.80 | $0.80 | $0.80 | $0.80 | $0.75 | $0.75 | $0.75 | $0.75 | $0.71 | $0.71 | $0.71 | $0.71 | $0.66 | $0.66 | |
| EPS (TTM) | $9.42 | $9.05 | · | $8.52 | $8.35 | $7.91 | · | $7.44 | $7.41 | $7.43 | · | $6.71 | $6.92 | $6.83 | · | $10.16 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.56B | $11.28B | · | $10.85B | $10.52B | $10.16B | · | $9.54B | $9.35B | $9.29B | · | $9.30B | $9.49B | $9.60B | · | $10.29B | |
| Net Income TTM | $1.06B | $1.02B | · | $969M | $950M | $897M | · | $841M | $840M | $846M | · | $763M | $794M | $793M | · | $1.24B | |
| Market Cap | $23.31B | $21.75B | · | $21.15B | $20.12B | $18.95B | · | $17.39B | $15.19B | $14.78B | · | $13.65B | $15.74B | $15.85B | · | $13.99B | |
| Enterprise Value | $28.33B | $21.86B | · | $21.23B | $20.30B | $18.76B | · | $22.88B | $15.53B | $15.21B | · | $13.81B | $16.13B | $15.67B | · | $13.29B | |
| P/E | 22.5 | 21.7 | · | 22.4 | 21.5 | 21.4 | · | 20.9 | 18.5 | 17.9 | · | 18.2 | 20.3 | 20.7 | · | 12.1 | |
| P/S | 2.0 | 1.9 | · | 1.9 | 1.9 | 1.9 | · | 1.8 | 1.6 | 1.6 | · | 1.5 | 1.7 | 1.7 | · | 1.4 | |
| P/B | 3.1 | 3.0 | · | 2.9 | 2.8 | 2.7 | · | 2.6 | 2.3 | 2.3 | · | 2.1 | 2.5 | 2.6 | · | 2.2 | |
| P / Cash Flow | · | 78.3 | · | · | · | 60.4 | · | · | · | 95.9 | · | · | · | 168.6 | · | · | |
| EV / Revenue | 2.5 | 1.9 | · | 2.0 | 1.9 | 1.8 | · | 2.4 | 1.7 | 1.6 | · | 1.5 | 1.7 | 1.6 | · | 1.3 | |
| Dividend Yield | 1.6% | 1.6% | · | 1.6% | 1.7% | 1.8% | · | 1.9% | 2.1% | 2.2% | · | 2.3% | 1.9% | 1.9% | · | 2.2% | |
| Earnings Yield | 4.4% | 4.6% | · | 4.5% | 4.7% | 4.7% | · | 4.8% | 5.4% | 5.6% | · | 5.5% | 4.9% | 4.8% | · | 8.3% | |
| Payout Ratio | · | 34.9% | · | · | · | 38.2% | · | · | · | 40.7% | · | · | · | 36.6% | · | · | |
| Annual Payout | $363M | $357M | · | $347M | $342M | $336M | · | $327M | $323M | $319M | · | $309M | $307M | $305M | · | $307M |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| परिचालन मार्जिन % | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% |
| शुद्ध आय | $992M | $871M | $854M | $946M | $2.00B |
| तनुकरणित EPS | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 |
| वर्तमान अनुपात | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 |
| त्वरित अनुपात | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $1.36B | $909M | $864M | $1.31B | $1.83B |
संस्थागत मालिक (13F) 1170 फाइलर्स · $23.2B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
धारक
1170
धारित मूल्य
$23.2B
नई स्थितियाँ
118
बाहर निकली पोजीशन
64
संस्थागत गतिविधि — Q2 2026 बनाम पिछली तिमाही
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 118 (-23 पिछली तिमाही की तुलना में) | 64 (-18 पिछली तिमाही की तुलना में) | 430 (+89 पिछली तिमाही की तुलना में) | 343 (-26 पिछली तिमाही की तुलना में) | +3.8M |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2497458052 | 14392082 | 10.79% | शेयर |
| BlackRock, Inc. | $1965923399 | 9275411 | 8.49% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $1533117858 | 7233394 | 6.62% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1299474988 | 6131045 | 5.61% | शेयर |
| STATE STREET CORP | $1169252484 | 5516643 | 5.05% | शेयर |
| Boston Partners | $1004552880 | 4744473 | 4.34% | शेयर |
| JPMORGAN CHASE & CO | $748586197 | 3520438 | 3.23% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $662582607 | 3137873 | 2.86% | शेयर |
| MORGAN STANLEY | $521503271 | 2460497 | 2.25% | शेयर |
| EdgePoint Investment Group Inc. | $476372038 | 2247568 | 2.06% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $421376156 | 1988048 | 1.82% | शेयर |
| BANK OF AMERICA CORP /DE/ | $410151497 | 1935133 | 1.77% | शेयर |
| Grantham, Mayo, Van Otterloo & Co. LLC | $400206122 | 1888207 | 1.73% | शेयर |
| WELLS FARGO & COMPANY/MN | $371171119 | 1751220 | 1.60% | शेयर |
| Davis Selected Advisers | $329781509 | 1555612 | 1.42% | शेयर |
| VICTORY CAPITAL MANAGEMENT INC | $311037928 | 1467506 | 1.34% | शेयर |
| NORGES BANK | $298133109 | 1406620 | 1.29% | शेयर |
| FMR LLC | $296462102 | 1398735 | 1.28% | शेयर |
| Invesco Ltd. | $292303423 | 1379115 | 1.26% | शेयर |
| NORTHERN TRUST CORP | $238963873 | 1127454 | 1.03% | शेयर |
| GOLDMAN SACHS GROUP INC | $208282052 | 982694 | 0.90% | शेयर |
| UBS Group AG | $188403627 | 888906 | 0.81% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $173422135 | 818220 | 0.75% | शेयर |
| M&G PLC | $168677800 | 795650 | 0.73% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $165917256 | 846603 | 0.72% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $163988047 | 773711 | 0.71% | शेयर |
| AMERIPRISE FINANCIAL INC | $161076730 | 759975 | 0.70% | शेयर |
| Legal & General Group Plc | $151986161 | 717085 | 0.66% | शेयर |
| Bank of New York Mellon Corp | $133388337 | 629339 | 0.58% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $131756386 | 621639 | 0.57% | शेयर |
| DEUTSCHE BANK AG\ | $124180445 | 585895 | 0.54% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $122662706 | 625894 | 0.53% | शेयर |
| Nuveen, LLC | $119503667 | 563830 | 0.52% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $109630811 | 517225 | 0.47% | शेयर |
| RAYMOND JAMES FINANCIAL INC | $107196222 | 505762 | 0.46% | शेयर |
| Amundi | $105710274 | 498751 | 0.46% | शेयर |
| Woodline Partners LP | $102974000 | 485841 | 0.44% | शेयर |
| FIDUCIARY MANAGEMENT INC /WI/ | $102489906 | 483557 | 0.44% | शेयर |
| Artemis Investment Management LLP | $99175856 | 467921 | 0.43% | शेयर |
| CRAWFORD INVESTMENT COUNSEL INC | $97514204 | 460081 | 0.42% | शेयर |
| BARCLAYS PLC | $95107474 | 448726 | 0.41% | शेयर |
| ENVESTNET ASSET MANAGEMENT INC | $90834224 | 428564 | 0.39% | शेयर |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $88822918 | 417715 | 0.38% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $83772178 | 395245 | 0.36% | शेयर |
| M.D. Sass, LLC | $76397960 | 360453 | 0.33% | शेयर |
| Qube Research & Technologies Ltd | $72783206 | 343398 | 0.31% | शेयर |
| MACKENZIE FINANCIAL CORP | $70641875 | 333295 | 0.31% | शेयर |
| Advisors Capital Management, LLC | $69429626 | 327575 | 0.30% | शेयर |
| CITIGROUP INC | $66888058 | 315584 | 0.29% | शेयर |
| Swiss National Bank | $65683305 | 309900 | 0.28% | शेयर |
कार्यकर्ता और 5%+ मालिक 13 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | 18 मई 2011 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 1 फ़रवरी 2011 | · | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 20 मार्च 2009 | · | प्रारंभिक फाइलिंग | · | SEC |
| GlaxoSmithKline plc ×2 फाइलिंग | 18 सितमबर 2008 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 16 फ़रवरी 2007 | · | प्रारंभिक फाइलिंग | · | SEC |
| Quest Diagnostics Incorporated - (FEIN No. ×2 फाइलिंग | 19 जनवरी 2006 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 15 दिसमबर 2004 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 29 जून 2004 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 24 जून 2002 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 22 मई 2002 | · | प्रारंभिक फाइलिंग | · | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 12 अप्रैल 2002 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| IRS Identification Nos. of Above Persons (entities only) Quest Diagnostics Ventures LLC - (FEIN No., Quest Diagnostics Incorporated - (FEIN No. ×3 फाइलिंग | 1 नवमबर 2001 | · | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| अघोषित रिपोर्टिंग व्यक्ति | 14 मई 2001 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 52 इनसाइडर्स · 26 अधिकारी · 26 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| E. J. Davis | CEO and President | 1 सितमबर 2026 S | 122423 | 0 | 6 | $-17083502 |
| Surya N Mohapatra | Chairman, President & CEO | 30 अप्रैल 2012 F | 243713 | 0 | 0 | $0 |
| Sam Samad | Executive Vice President & CFO | 22 जुलाई 2026 A | 33478 | 0 | 0 | $0 |
| Mark Guinan | Executive Vice President & CFO | 7 मार्च 2022 F | 98981 | 0 | 0 | $0 |
| Robert Hagemann | SVP & Chief Financial Officer | 5 मार्च 2013 F | 126722 | 0 | 0 | $0 |
| Michael E Prevoznik | SVP & General Counsel | 28 अगस्त 2026 M | 36557 | 0 | 6 | $-6649682 |
| Mark E Delaney | SVP & Chief Commercial Officer | 28 जुलाई 2026 S | 10335 | 0 | 2 | $-1864971 |
| Karthik Kuppusamy | SVP, Clinical Solutions | 22 जुलाई 2026 L | 13557 | 0 | 2 | $-2167772 |
| Patrick Plewman | SVP for Diagnostic Services | 22 जुलाई 2026 L | 15293 | 0 | 4 | $-2025174 |
| Catherine T. Doherty | EVP, Regional Businesses | 5 मार्च 2026 S | 67122 | 0 | 8 | $-6964749 |
| Michael J Deppe | SVP, Corp. Controller & CAO | 4 मार्च 2026 F | 35196 | 0 | 0 | $0 |
| Mark A Gardner | SVP of Molecular Gen & Oncol | 24 सितमबर 2024 F | 4673 | 0 | 0 | $0 |
| Manner Carrie Eglinton | SVP, Advanced Diagnostics | 7 मार्च 2022 F | 48391 | 0 | 0 | $0 |
| Manuel O. Mendez | SVP & Chief Commercial Officer | 17 फ़रवरी 2021 A | 29045 | 0 | 0 | $0 |
| Robert A Klug | VP, Corporate Controller | 1 मार्च 2019 F | 6261 | 0 | 0 | $0 |
| Jon R Cohen | SVP & Group Exec. Diag. Sol. | 8 मार्च 2018 M | 31757 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Commercial | 1 मार्च 2018 G | 37760 | 0 | 0 | $0 |
| Thomas F Bongiorno | VP and Corporate Controller | 2 मार्च 2015 F | 11837 | 0 | 0 | $0 |
| John B. Haydon | SVP, Operations | 13 फ़रवरी 2014 A | 19890 | 0 | 0 | $0 |
| Kathy Ordonez | SVP, Diagnostic Solutions | 31 मार्च 2013 F | 9569 | 0 | 0 | $0 |
| Joan Elizabeth Miller | SVP-Oncology & Neurology Srvcs | 29 फ़रवरी 2012 F | 89232 | 0 | 0 | $0 |
| Wayne R. Simmons | Vice President, Operations | 16 जून 2011 M | 47150 | 0 | 0 | $0 |
| Robert E Peters | VP, Sales & Marketing | 12 फ़रवरी 2007 A | 12974 | 0 | 0 | $0 |
| David M Zewe | SVP, Diagnostic Testing Ops | 12 फ़रवरी 2007 A | 31079 | 0 | 0 | $0 |
| GRANT THOMAS W II | Sr VP, Ins. & Employer Serv. | 12 फ़रवरी 2007 A | · | 0 | 0 | $0 |
| Gerald C Marrone | SVP, Administration | 28 फ़रवरी 2004 F | 49609 | 0 | 0 | $0 |
| Timothy C Wentworth | निदेशक | 1 अक्टूबर 2026 A | 1358 | 0 | 0 | $0 |
| Wright Lassiter III | निदेशक | 22 जुलाई 2026 L | 10323 | 0 | 0 | $0 |
| Vicky B Gregg | निदेशक | 22 जुलाई 2026 A | 18386 | 0 | 1 | $-239700 |
| Robert B Carter | निदेशक | 22 जुलाई 2026 L | 3864 | 0 | 0 | $0 |
| Timothy L Main | निदेशक | 22 जुलाई 2026 L | 22460 | 0 | 0 | $0 |
| Luis Diaz | निदेशक | 20 मई 2026 A | 5196 | 0 | 0 | $0 |
| Tracey Doi | निदेशक | 20 मई 2026 A | 7748 | 0 | 0 | $0 |
| Timothy M Ring | निदेशक | 20 मई 2026 A | 31140 | 0 | 0 | $0 |
| Gary M Pfeiffer | निदेशक | 20 मई 2026 A | 31005 | 0 | 1 | $-270317 |
| Gail R Wilensky | निदेशक | 17 मई 2023 A | 20506 | 0 | 0 | $0 |
| Stephen H Rusckowski | निदेशक | 6 मार्च 2023 F | 389597 | 0 | 0 | $0 |
| Helen Torley | निदेशक | 25 मई 2021 A | 6260 | 0 | 0 | $0 |
| Daniel Stanzione | निदेशक | 23 नवमबर 2020 S | 28349 | 0 | 0 | $0 |
| Jenne K Britell | निदेशक | 4 जून 2018 G | 14479 | 0 | 0 | $0 |
| Jeffrey M Leiden | निदेशक | 29 मई 2018 S | 6000 | 0 | 0 | $0 |
| John B Ziegler | निदेशक | 22 फ़रवरी 2017 S | 16557 | 0 | 0 | $0 |
| John C Baldwin MD | निदेशक | 12 अगस्त 2015 S | 12949 | 0 | 0 | $0 |
| William F Buehler | निदेशक | 12 फ़रवरी 2014 M | 26225 | 0 | 0 | $0 |
| GSK plc | निदेशक | 31 जनवरी 2011 S | 0 | 0 | 0 | $0 |
| Rosanne Haggerty | निदेशक | 6 मई 2010 A | 9334 | 0 | 0 | $0 |
| William R Grant | निदेशक | 1 अप्रैल 2007 A | 3334 | 0 | 0 | $0 |
| James F Flaherty III | निदेशक | 4 मई 2006 A | 1667 | 0 | 0 | $0 |
| Kenneth D Brody | निदेशक | 28 अप्रैल 2004 S | 0 | 0 | 0 | $0 |
| Mary A Cirillo | निदेशक | 1 अप्रैल 2004 A | 2627 | 0 | 0 | $0 |
| Denise M Morrison | · | 20 मई 2026 A | 11929 | 0 | 0 | $0 |
| FREEMAN KENNETH W/NJ | · | 14 दिसमबर 2004 F | 216187 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 133 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| IHF · iShares Trust | 3.75% | 212725 SH | 11 सितमबर 2026 | दैनिक |
| RW · EA Series Trust | 2.50% | 1865 NS | 31 जुलाई 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.64% | 61314 SH | 5 अक्टूबर 2026 | दैनिक |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.49% | 67178 NS | 31 जुलाई 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1.28% | 11113 SH | 5 अक्टूबर 2026 | दैनिक |
| NUDV · Nushares ETF Trust | 1.09% | 2338 NS | 31 जुलाई 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0.97% | 637 NS | 31 जुलाई 2026 | N-PORT |
| SPLV · Invesco Exchange-Traded Fund Trust … | 0.88% | 262758 SH | 5 अक्टूबर 2026 | दैनिक |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.79% | 4469 SH | 5 अक्टूबर 2026 | दैनिक |
| JOET · Virtus ETF Trust II | 0.78% | 8139 NS | 31 जुलाई 2026 | N-PORT |
| ESMV · iShares Trust | 0.70% | 236 SH | 11 सितमबर 2026 | दैनिक |
| QLV · FlexShares Trust | 0.63% | 4452 NS | 31 जुलाई 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0.60% | 1903 NS | 31 जुलाई 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0.46% | 369448 NS | 31 जुलाई 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.43% | 8600 NS | 31 जुलाई 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.43% | 8453 NS | 31 जुलाई 2026 | N-PORT |
| IYH · iShares Trust | 0.41% | 64629 SH | 11 सितमबर 2026 | दैनिक |
| VOE · VANGUARD INDEX FUNDS | 0.40% | 711079 SH | 19 अगस्त 2026 | दैनिक |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.38% | 22688 NS | 31 जुलाई 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.37% | 52313 NS | 31 जुलाई 2026 | N-PORT |
| IMCV · iShares Trust | 0.36% | 18030 SH | 11 सितमबर 2026 | दैनिक |
| SUSA · iShares Trust | 0.34% | 59240 SH | 11 सितमबर 2026 | दैनिक |
| VHT · VANGUARD WORLD FUND | 0.34% | 330273 SH | 19 अगस्त 2026 | दैनिक |
| IXJ · iShares Trust | 0.32% | 58047 SH | 11 सितमबर 2026 | दैनिक |
| DFLV · Dimensional ETF Trust | 0.30% | 87905 NS | 31 जुलाई 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.30% | 19944 NS | 31 जुलाई 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.30% | 2178 NS | 31 जुलाई 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0.27% | 3540 NS | 31 जुलाई 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0.26% | 9337 NS | 31 जुलाई 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.26% | 27542 NS | 31 जुलाई 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.25% | 7574000 | 5 अक्टूबर 2026 | दैनिक |
| IWS · iShares Trust | 0.25% | 165299 SH | 11 सितमबर 2026 | दैनिक |
| ESUM · Strategy Shares | 0.24% | 1901 NS | 31 जुलाई 2026 | N-PORT |
| SIZE · iShares Trust | 0.24% | 4359 SH | 11 सितमबर 2026 | दैनिक |
| VO · VANGUARD INDEX FUNDS | 0.23% | 2398948 SH | 19 अगस्त 2026 | दैनिक |
| VFMV · VANGUARD WELLINGTON FUND | 0.22% | 4307 SH | 19 अगस्त 2026 | दैनिक |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 827048 SH | 5 अक्टूबर 2026 | दैनिक |
| ACWV · iShares, Inc. | 0.20% | 28973 SH | 11 सितमबर 2026 | दैनिक |
| EUSA · iShares, Inc. | 0.19% | 16140 SH | 11 सितमबर 2026 | दैनिक |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.19% | 1371 NS | 31 जुलाई 2026 | N-PORT |
| IWR · iShares Trust | 0.19% | 452857 SH | 11 सितमबर 2026 | दैनिक |
| IMCB · iShares Trust | 0.18% | 12959 SH | 11 सितमबर 2026 | दैनिक |
| MTUM · iShares Trust | 0.16% | 168369 SH | 11 सितमबर 2026 | दैनिक |
| DFVX · Dimensional ETF Trust | 0.16% | 3609 NS | 31 जुलाई 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.15% | 97399 NS | 31 जुलाई 2026 | N-PORT |
| ESLG · Strategy Shares | 0.15% | 146 NS | 31 जुलाई 2026 | N-PORT |
| XOEF · iShares Trust | 0.15% | 140 SH | 11 सितमबर 2026 | दैनिक |
| CATH · Global X Funds | 0.12% | 6867 NS | 31 जुलाई 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.12% | 165000 | 1 अक्टूबर 2026 | दैनिक |
| ROUS · Lattice Strategies Trust | 0.12% | 3633 NS | 31 जुलाई 2026 | N-PORT |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0.12% | 115349 SH | 5 अक्टूबर 2026 | दैनिक |
| EVUS · iShares Trust | 0.11% | 1865 SH | 11 सितमबर 2026 | दैनिक |
| VIG · VANGUARD SPECIALIZED FUNDS | 0.10% | 625384 SH | 19 अगस्त 2026 | दैनिक |
| VYM · VANGUARD WHITEHALL FUNDS | 0.10% | 440583 SH | 19 अगस्त 2026 | दैनिक |
| DGRO · iShares Trust | 0.10% | 179879 SH | 11 सितमबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 3271 SH | 5 अक्टूबर 2026 | दैनिक |
| PFM · Invesco Exchange-Traded Fund Trust | 0.09% | 3153 SH | 5 अक्टूबर 2026 | दैनिक |
| VTV · VANGUARD INDEX FUNDS | 0.09% | 1051572 SH | 19 अगस्त 2026 | दैनिक |
| DXUV · Dimensional ETF Trust | 0.09% | 2092 NS | 31 जुलाई 2026 | N-PORT |
| CRBN · iShares Trust | 0.09% | 4406 SH | 11 सितमबर 2026 | दैनिक |
| DCOR · Dimensional ETF Trust | 0.09% | 12279 NS | 31 जुलाई 2026 | N-PORT |
| IVE · iShares Trust | 0.09% | 183297 SH | 11 सितमबर 2026 | दैनिक |
| IUSV · iShares Trust | 0.08% | 97344 SH | 11 सितमबर 2026 | दैनिक |
| DFAC · Dimensional ETF Trust | 0.08% | 167227 NS | 31 जुलाई 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.08% | 25423 SH | 19 अगस्त 2026 | दैनिक |
| CHRI · Global X Funds | 0.08% | 27 NS | 31 जुलाई 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0.08% | 1095 NS | 31 जुलाई 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.08% | 3155 SH | 5 अक्टूबर 2026 | दैनिक |
| SUSL · iShares Trust | 0.08% | 3907 SH | 11 सितमबर 2026 | दैनिक |
| ILCV · iShares Trust | 0.07% | 4337 SH | 11 सितमबर 2026 | दैनिक |
| DSI · iShares Trust | 0.07% | 16854 SH | 11 सितमबर 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.07% | 66643 SH | 19 अगस्त 2026 | दैनिक |
| IWD · iShares Trust | 0.07% | 245078 SH | 11 सितमबर 2026 | दैनिक |
| HDUS · Lattice Strategies Trust | 0.07% | 586 NS | 31 जुलाई 2026 | N-PORT |
| EGLE · Global X Funds | 0.06% | 6 NS | 31 जुलाई 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0.06% | 3 NS | 31 जुलाई 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.06% | 24840 SH | 5 अक्टूबर 2026 | दैनिक |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.06% | 24539 SH | 5 अक्टूबर 2026 | दैनिक |
| DFSU · Dimensional ETF Trust | 0.05% | 5056 NS | 31 जुलाई 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.05% | 26447 NS | 31 जुलाई 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.05% | 9857 SH | 5 अक्टूबर 2026 | दैनिक |
| TOPC · iShares Trust | 0.05% | 68 SH | 11 सितमबर 2026 | दैनिक |
| XVV · iShares Trust | 0.04% | 1285 SH | 11 सितमबर 2026 | दैनिक |
| XYLD · Global X Funds | 0.04% | 6096 NS | 31 जुलाई 2026 | N-PORT |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.04% | 3131 SH | 5 अक्टूबर 2026 | दैनिक |
| BKLC · BNY Mellon ETF Trust | 0.04% | 9574 NS | 31 जुलाई 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.04% | 15319 NS | 31 जुलाई 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.04% | 2875103 SH | 19 अगस्त 2026 | दैनिक |
| VV · VANGUARD INDEX FUNDS | 0.04% | 129285 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.04% | 24972 SH | 19 अगस्त 2026 | दैनिक |
| TOV · EA Series Trust | 0.04% | 426 NS | 31 जुलाई 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.04% | 5593 NS | 31 जुलाई 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.04% | 1876 NS | 31 जुलाई 2026 | N-PORT |
| XYLG · Global X Funds | 0.04% | 109 NS | 31 जुलाई 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.04% | 655 SH | 5 अक्टूबर 2026 | दैनिक |
| XCLR · Global X Funds | 0.04% | 6 NS | 31 जुलाई 2026 | N-PORT |
| IVV · iShares Trust | 0.04% | 1392389 SH | 11 सितमबर 2026 | दैनिक |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.04% | 17947 SH | 5 अक्टूबर 2026 | दैनिक |
| XTR · Global X Funds | 0.04% | 8 NS | 31 जुलाई 2026 | N-PORT |
| ILCB · iShares Trust | 0.04% | 2144 SH | 11 सितमबर 2026 | दैनिक |
| XRMI · Global X Funds | 0.04% | 82 NS | 31 जुलाई 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.04% | 33588 NS | 31 जुलाई 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.04% | 417 NS | 31 जुलाई 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.04% | 2663 NS | 31 जुलाई 2026 | N-PORT |
| IWB · iShares Trust | 0.04% | 76198 SH | 11 सितमबर 2026 | दैनिक |
| VOXP · Advisors Series Trust | 0.04% | 9 NS | 31 जुलाई 2026 | N-PORT |
| IYY · iShares Trust | 0.04% | 4688 SH | 11 सितमबर 2026 | दैनिक |
| IWV · iShares Trust | 0.03% | 30298 SH | 11 सितमबर 2026 | दैनिक |
| ITOT · iShares Trust | 0.03% | 141099 SH | 11 सितमबर 2026 | दैनिक |
| PHDG · Invesco Actively Managed Exchange-T… | 0.03% | 88 SH | 5 अक्टूबर 2026 | दैनिक |
| HCMT · Direxion Shares ETF Trust | 0.03% | 772 NS | 31 जुलाई 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.03% | 3515122 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.03% | 18213 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.03% | 9300 SH | 19 अगस्त 2026 | दैनिक |
| SPXL · Direxion Shares ETF Trust | 0.03% | 8650 NS | 31 जुलाई 2026 | N-PORT |
| URTH · iShares, Inc. | 0.03% | 10177 SH | 11 सितमबर 2026 | दैनिक |
| TILT · FlexShares Trust | 0.03% | 2686 NS | 31 जुलाई 2026 | N-PORT |
| TOK · iShares Trust | 0.03% | 292 SH | 11 सितमबर 2026 | दैनिक |
| ACWI · iShares Trust | 0.03% | 36161 SH | 11 सितमबर 2026 | दैनिक |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 95097 SH | 19 अगस्त 2026 | दैनिक |
| DYNF · BlackRock ETF Trust | 0.02% | 34844 SH | 11 सितमबर 2026 | दैनिक |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 1000 | 30 सितमबर 2026 | दैनिक |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| VCEB · VANGUARD WORLD FUND | · | · | 30 जुलाई 2026 | दैनिक |
DGX विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
रेटिंग · 23 विश्लेषक
खरीदें
मध्यिका लक्ष्य
$250.00
+9.5%
6 26.1%
मजबूत खरीद
7 30.4%
खरीदें
10 43.5%
होल्ड
0 0.0%
बेचें
0 0.0%
मजबूत बिक्री
12-महीने का मूल्य लक्ष्य
15 विश्लेषक · 2026-10-04माध्य लक्ष्य $247.73 +8.5%
अभी
वर्तमान मूल्य $228.39
निम्न$204.00
माध्य$247.73
उच्च$265.00
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
स्रोत: SEC 10-Q जुल 23, 2026 को फाइल किया गया